Kayne Anderson Rudnick Investment Management LLC Charles River Laboratories International, Inc. Transaction History
Kayne Anderson Rudnick Investment Management LLC
- $39.3 Billion
- Q1 2025
A detailed history of Kayne Anderson Rudnick Investment Management LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Kayne Anderson Rudnick Investment Management LLC holds 1,950,273 shares of CRL stock, worth $292 Million. This represents 0.75% of its overall portfolio holdings.
Number of Shares
1,950,273
Previous 1,805,541
8.02%
Holding current value
$292 Million
Previous $333 Million
11.93%
% of portfolio
0.75%
Previous 0.79%
Shares
29 transactions
Others Institutions Holding CRL
# of Institutions
612Shares Held
54.9MCall Options Held
722KPut Options Held
847K-
Vanguard Group Inc Valley Forge, PA6.11MShares$914 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$762 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$642 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$358 Million0.07% of portfolio
-
Allspring Global Investments Holdings, LLC2.29MShares$343 Million0.63% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.62B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...